FABP4 and Other metabolic disease: After its discovery in 1972, A-FABP, a small cytosolic polypeptide abundantly expressed in tissues with active lipid metabolism, such as the heart and liver or cells specialized for lipid storage, trafficking, and signaling such as adipocytes and macrophages, was well known to be associated with several metabolic disorders and CVD [12,13].